Please login to the form below

Not currently logged in
Email:
Password:

EDCTP

This page shows the latest EDCTP news and features for those working in and with pharma, biotech and healthcare.

EU boost for GSK's Ebola vaccine research

EU boost for GSK's Ebola vaccine research

1.8. The Commission has also asked the European and Developing Countries Clinical Trials Partnership (EDCTP) to include emerging epidemics of concern to Africa, including Ebola, in its work plan. ... This will allow EDCTP, which has been running since

Latest news

  • Europe extends clinical trial project with African researchers Europe extends clinical trial project with African researchers

    The European &Developing Countries Clinical Trials Partnership (EDCTP) was first set up in 2003 and focuses on phase I to IV research into diseases such as HIV/AIDS, tuberculosis and malaria, ... Granting full membership of EDCTP to African countries

  • Europe builds links with African researchers Europe builds links with African researchers

    Europe builds links with African researchers. EDCTP and EFPIA launch fellowship scheme for Africans to spend time at European pharma firms. ... The European &Developing Countries Clinical Trials Partnership (EDCTP) and the European Federation of

More from news
Approximately 2 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Interview: Charles Mgone, EDCTP Interview: Charles Mgone, EDCTP

    Prof Mgone has been executive director of the European and Developing Countries Clinical Trials Partnership (EDCTP) since February 2007. ... EDCTP offers a more cost-effective and unified means of tackling poverty-related diseases.”.

More from intelligence
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...

Infographics